CNA Financial (NYSE: CNA) executive files to sell 6,250 common shares

Rhea-AI Filing Summary

Dino Robusto, associated with CNA Financial, filed a Rule 144 notice to sell 6,250 shares of CNA common stock through Fidelity Brokerage Services, with an aggregate market value of $297,625.00, on or after 01/02/2026 on the NYSE. These shares were acquired on 03/15/2023 via vesting of a performance share plan.

In the past three months, Robusto reported separate sales of 6,250 shares of CNA common stock on 10/01/2025, 11/03/2025, and 12/01/2025, with gross proceeds of $289,062.50, $283,000.00, and $293,250.00, respectively. CNA common shares outstanding were 270,665,399 at the time referenced in the notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	6250	297625.00	270665399	01/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2023	Vesting of PSP	Issuer			6250	03/15/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Dino Robusto c/o CNA Financial Corp 151 N. FRANKLIN Chicago IL 60606	Common Stock	11/03/2025	6250	283000.00
Dino Robusto c/o CNA Financial Corp 151 N. FRANKLIN Chicago IL 60606	Common Stock	12/01/2025	6250	293250.00
Dino Robusto c/o CNA Financial Corp 151 N. FRANKLIN Chicago IL 60606	Common Stock	10/01/2025	6250	289062.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transaction is disclosed for CNA (CNA) in this Rule 144 notice?

The notice reports that Dino Robusto intends to sell 6,250 shares of CNA Financial common stock under Rule 144. The planned sale is through Fidelity Brokerage Services LLC on or after 01/02/2026 on the NYSE, with an aggregate market value listed as $297,625.00.

How and when did the CNA (CNA) insider acquire the 6,250 shares being sold?

The 6,250 common shares to be sold were acquired on 03/15/2023 through the vesting of a performance share plan (PSP). The issuer is shown as the party from whom the shares were acquired, and the transaction is not marked as a gift.

What recent sales of CNA (CNA) stock has Dino Robusto reported in the last 3 months?

Over the prior three months, Dino Robusto reported three separate sales of 6,250 shares of CNA common stock each. The sales occurred on 10/01/2025 for $289,062.50, on 11/03/2025 for $283,000.00, and on 12/01/2025 for $293,250.00 in gross proceeds.

How many CNA (CNA) common shares are outstanding according to this notice?

The Rule 144 notice lists 270,665,399 CNA Financial common shares as outstanding. This figure is provided as a share count reference in the securities information section.

Which broker and exchange are involved in the planned CNA (CNA) share sale?

The planned sale of 6,250 CNA common shares is to be executed through Fidelity Brokerage Services LLC, located at 245 Summer Street, Boston, MA 02110, with the securities listed for sale on the NYSE.

What does the Rule 144 representation by the CNA (CNA) insider state?

The signer represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. If relying on a written trading plan or instructions under Rule 10b5-1, the signer makes that representation as of the plan adoption or instruction date.